Acceptability of second-step treatments to depressed outpatients: A STAR*D report

Stephen R. Wisniewski, Maurizio Fava, Madhukar H. Trivedi, Michael E. Thase, Diane Warden, George Niederehe, Edward S. Friedman, Melanie M. Biggs, Harold A. Sackeim, Kathy Shores-Wilson, Patrick J. McGrath, Philip W. Lavori, Sachiko Miyahara, A. John Rush

Research output: Contribution to journalArticle

56 Scopus citations

Abstract

Objective: Treatment of major depressive disorder typically entails implementing treatments in a stepwise fashion until a satisfactory outcome is achieved. This study sought to identify factors that affect patients' willingness to accept different second-step treatment approaches. Method: Participants in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial who had unsatisfactory outcomes after initial treatment with citalopram were eligible for a randomized second-step treatment trial. An equipoise-stratified design allowed participants to exclude or include specific treatment strategies. Analyses were conducted to identify factors associated with the acceptability of the following second-step treatments: cognitive therapy versus no cognitive therapy, any switch strategy versus any augmentation strategy (including cognitive therapy), and a medication switch strategy only versus a medication augmentation strategy only. Results: Of the 1,439 participants who entered second-step treatment, 1% accepted all treatment strategies, 3% accepted only cognitive therapy, and 26% accepted cognitive therapy (thus, 71% did not accept cognitive therapy). Those with higher educational levels or a family history of a mood disorder were more likely to accept cognitive therapy. Participants in primary care settings and those who experienced a greater side effect burden or a lower reduction in symptom severity with citalopram were more likely to accept a switch strategy as compared with an augmentation strategy. Those with concurrent drug abuse and recurrent major depressive disorder were less likely to accept a switch strategy. Conclusions: Few participants accepted all treatments. Acceptance of cognitive therapy was primarily associated with sociodemographic characteristics, while acceptance of a treatment switch was associated with the results of the initial treatment.

Original languageEnglish (US)
Pages (from-to)753-760
Number of pages8
JournalAmerican Journal of Psychiatry
Volume164
Issue number5
DOIs
StatePublished - May 2007

ASJC Scopus subject areas

  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Acceptability of second-step treatments to depressed outpatients: A STAR*D report'. Together they form a unique fingerprint.

  • Cite this

    Wisniewski, S. R., Fava, M., Trivedi, M. H., Thase, M. E., Warden, D., Niederehe, G., Friedman, E. S., Biggs, M. M., Sackeim, H. A., Shores-Wilson, K., McGrath, P. J., Lavori, P. W., Miyahara, S., & Rush, A. J. (2007). Acceptability of second-step treatments to depressed outpatients: A STAR*D report. American Journal of Psychiatry, 164(5), 753-760. https://doi.org/10.1176/ajp.2007.164.5.753